Johnson & Johnson Announces CE Mark for CEREGLIDE™ 42, CEREGLIDE™ 57, CEREGLIDE™ 71 and INNERGLIDE™ 7 28 May 2026
Johnson & Johnson Highlights Favorable 12-Month Interim Results for the VARIPULSE Platform at EHRA 2026 01 May 2026
Johnson & Johnson Advances Pulsed Field Ablation Portfolio with the Launch of VARIPULSE Pro in Europe 07 April 2026
New Report from the Lung Cancer Screening European Expert Summit Makes the Case for Lung Cancer Screening to Enable Early Detection and Life-Saving Surgery 24 November 2025
Newly Published European Research Reveals that Gaps in Communication and Continuity of Care Are Impacting Patient Recovery from Lung Cancer Surgery¹ 01 November 2025
Johnson & Johnson Announces Launch of its Shockwave Javelin Peripheral Intravascular Lithotripsy Catheter in Europe to Transform Treatment of Difficult-to-Cross Calcified Lesions 15 September 2025
Johnson & Johnson Presents New Real-World Data for TECNIS PureSee™ IOL at ESCRS 2025 14 September 2025
